FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 355:2048 November 9, 2006 Number 19 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Braude, P. PubMed Citation

To the Editor: In his Perspective article on preimplantation diagnosis for genetic susceptibility (Aug. 10 issue),¹ an English colleague, Braude, asserts that assisted reproductive technology is unregulated in the United States. There are profound differences in the medical regulatory and certification processes between the United States and the United Kingdom. The many reasons for these differences have long-standing historical precedents but include political, fiscal, and social determinants. Nevertheless, it is incorrect to call assisted reproductive technology in the United States unregulated. Federal law requires the Centers for Disease Control and Prevention to publish annual outcomes associated with assisted reproductive technology . . . [Full Text of this Article]

This article has been cited by other articles:

• Julian-Reynier, C., Chabal, F., Frebourg, T., Lemery, D., Nogues, C., Puech, F., Stoppa-Lyonnet, D. (2009). Professionals Assess the Acceptability of Preimplantation Genetic Diagnosis and Prenatal Diagnosis for Managing Inherited Predisposition to Cancer. JCO 27: 4475-4480 [Abstract] [Full Text]  
• Uluckan, O., Becker, S. N., Deng, H., Zou, W., Prior, J. L., Piwnica-Worms, D., Frazier, W. A., Weilbaecher, K. N. (2009). CD47 Regulates Bone Mass and Tumor Metastasis to Bone. Cancer Res. 69: 3196-3204 [Abstract] [Full Text]